Managers / Q4 2025 · view latest →
Hedeker Wealth, LLC
CIK 0001633910 · ONE OVERLOOK POINT, SUITE 610, LINCOLNSHIRE, IL, 60069 · 847-913-5594
Summary
Hedeker Wealth, LLC reported $477M in U.S.-listed holdings across 87 positions for Q4 2025.
Its largest position, PLTR, represents 7.8% of the portfolio.
Compared with Q3 2025, the fund opened 2 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 75.4% · $359M
- ETP · 20.5% · $97M
- Other · 3.7% · $17M
- REIT · 0.5% · $2M
- ADR · 0.0% · $63,781
Quarter-over-Quarter Changes full breakdown →
vs Q3 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| IBKRINTERACTIVE BROKERS GROUP IN | NEW | +28.4K | 28.4K | +$2M | $2M |
| PGIM ETF TR | NEW | +6.2K | 6.2K | +$310,080 | $310,080 |
| LLYELI LILLY & CO | ADDED | +7.2K | 9.1K | +$8M | $10M |
| GTLSCHART INDS INC | SOLD OUT | −15.5K | 0 | −$3M | $0 |
| ADPTADAPTIVE BIOTECHNOLOGIES COR | SOLD OUT | −121.7K | 0 | −$2M | $0 |
| PIMCO ETF TR | SOLD OUT | −37.3K | 0 | −$2M | $0 |
| ABBVABBVIE INC | SOLD OUT | −3.7K | 0 | −$861,097 | $0 |
| ABTABBOTT LABS | SOLD OUT | −5.7K | 0 | −$758,100 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $474M | 87 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $477M | 87 | Jan 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $481M | 92 | Oct 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $429M | 89 | Aug 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $372M | 87 | May 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $402M | 85 | Jan 27, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $377M | 83 | Oct 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $345M | 85 | Jul 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $347M | 89 | Apr 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $317M | 88 | Jan 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $288M | 84 | Nov 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $300M | 91 | Jul 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $281M | 92 | Apr 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $268M | 92 | Jan 20, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $257M | 87 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $290M | 88 | Jul 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $330M | 80 | Apr 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $344M | 86 | Feb 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $324M | 89 | Oct 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $321M | 75 | Jul 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $285M | 65 | May 4, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $286M | 66 | Jan 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $211M | 67 | Oct 26, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $194M | 63 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $159M | 60 | Apr 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $187M | 58 | Jan 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $165M | 58 | Nov 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $158M | 56 | Jul 26, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $133M | 66 | Apr 22, 2019 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2018 | $125M | 68 | Jan 16, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.